Document Detail

Non platinum metal complexes as anti-cancer drugs.
MedLine Citation:
PMID:  17315259     Owner:  NLM     Status:  MEDLINE    
The development of metal complexes with platinum central atoms such as cisplatin or carboplatin had an enormous impact on current cancer chemotherapy. However, the spectrum of cancers that can be treated with platinum agents is narrow and treatment efficacy suffers from side effects and resistance phenomena. These unresolved problems in platinum-based anti-cancer therapy have stimulated increased research efforts in the search for novel non platinum-containing metal species as cytostatic agents. Preclinical and clinical investigations showed that the development of new metal agents with modes of action different from cisplatin is possible. Thus, complexes with iron, cobalt, or gold central atoms have shown promising results in preclinical studies and compounds with titanium, ruthenium, or gallium central atoms have already been evaluated in phase I and phase II trials. This review covers some relevant examples of preclinical and clinical research on novel non platinum metal complexes.
Ingo Ott; Ronald Gust
Related Documents :
2193999 - Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal can...
10482199 - Combination therapy with trastuzumab (herceptin) and cisplatin for chemoresistant metas...
17269699 - Self-assembled poly(butadiene)-b-poly(ethylene oxide) polymersomes as paclitaxel carriers.
15477639 - Hypersensitivity reactions to oxaliplatin and the application of a desensitization prot...
18378539 - New therapeutic directions for advanced pancreatic cancer: targeting the epidermal grow...
17065089 - Difference in ki67 and thymidylate synthase expression in primary tumour compared with ...
25209149 - Toward operative in vivo fluorescence imaging of the c-met proto-oncogene for personali...
17385189 - Decision-related uncertainties perceived by people with cancer--modelling the subject o...
16547849 - Predictive value of morphologic characteristics in rectosigmoid adenomatous polyps for ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Archiv der Pharmazie     Volume:  340     ISSN:  0365-6233     ISO Abbreviation:  Arch. Pharm. (Weinheim)     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-03-12     Completed Date:  2007-06-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0330167     Medline TA:  Arch Pharm (Weinheim)     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  117-26     Citation Subset:  IM    
Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / pharmacology*,  therapeutic use,  toxicity
Cobalt / pharmacology
Ferric Compounds / pharmacology
Ferrous Compounds / pharmacology
Gallium / pharmacology
Molecular Structure
Neoplasms / drug therapy*
Organogold Compounds / pharmacology
Organometallic Compounds / pharmacology*,  therapeutic use,  toxicity
Organoplatinum Compounds / pharmacology
Ruthenium Compounds / pharmacology
Titanium / pharmacology
Treatment Outcome
Reg. No./Substance:
0/Antineoplastic Agents; 0/Ferric Compounds; 0/Ferrous Compounds; 0/Organogold Compounds; 0/Organometallic Compounds; 0/Organoplatinum Compounds; 0/Ruthenium Compounds; 7440-32-6/Titanium; 7440-48-4/Cobalt; 7440-55-3/Gallium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Histochemical staining and quantification of dihydrolipoamide dehydrogenase diaphorase activity usin...
Next Document:  Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.